Tag:

drug development

Latest Headlines

Latest Headlines

MPI teams up with imaging outfits to woo drug developers

MPI Research is joining forces with InviCRO and 3D Imaging to open a state-of-the-art imaging center for drug discovery and development, pooling resources to create a one-stop shop.

GlaxoSmithKline chief says new-drug prices should drop as R&D improves

Here's a departure from the industry line for you. GlaxoSmithKline CEO Andrew Witty says that, one fine day, new drug prices should drop--sometimes even below the cost of the older drugs they replace.

U.K. wants CRO input on clinical trial reforms

The EU is looking to liberalize its clinical trial regulations to spur drug development in the Continent, and the U.K.'s Medicines and Healthcare products Regulatory Agency (MHRA) wants to hear from CROs and drugmakers on the proposed reforms.

Catalent looks to bridge industry, academia on drug delivery

Catalent Pharma Solutions is looking to promote innovation and collaboration between drug developers and academics, launching its Applied Drug Delivery Institute.

Icon teams with Dublin university for drug development

Icon has entered into a strategic partnership with University College Dublin, teaming up with its hometown school to develop drugs, fund a fellowship and help construct a new science center for the university.

Merck Serono bioinformatics head starts new company

Jérôme Wojcik, former director of bioinformatics at Merck Serono, is starting a new company, Quartz Bio, to do biomarker data management and exploratory biomarker analysis services that will be supported under Merck Serono's Entrepreneur Partnership Program, reports PharmaTimes.

10 Reasons Why Biotech Needs Big Data

We've rounded up 10 ways huge stockpiles of data and large-scale data analysis are changing the biotech game.

10 Reasons Why Biotech Needs Big Data

We've rounded up 10 ways huge stockpiles of data and large-scale data analysis are changing the biotech game.

Boehringer claims 'gamification' win in pharma

Video game magic has rubbed off on a pharma-sponsored competition. To harness the excitement that keeps video game players coming back for more, German drugmaker Boehringer Ingelheim held an online contest that challenged teams to create predictive data models for use in drug development.

Icon snatches up drug pricing guru PriceSpective

Dublin-based CRO Icon has snatched up PriceSpective, a 9-year-old consulting firm focused on market access, reimbursement and pharmaceutical pricing. Neither side is disclosing financial terms in...